Introducing pocket-friendly medicines in a price-sensitive market like India was a revolutionary strategy that made a big difference. "It t...

The company has for the last five years been ranked number one in the number of prescriptions. Manforce condoms, oral contraceptives Prega ...

Its shares are currently trading nearly 6.7% higher at Rs 1,387. The IPO received a strong response, with the issue subscribed for 15.32 ti...

The IPO, valued at Rs 4,326 crore, received an overwhelming response, being subscribed for 15.32 times due to interest from qualified insti...

Mankind Pharma's shares are commanding a premium of Rs 100-113 to its issue price of Rs 1,080 in the grey market. Research analysts predict...

Indian pharma company Mankind Pharma is set to open its IPO next week. The offer for sale of 40 million equity shares by promoters and othe...

Mankind is investing about ₹250-₹300 crore on the Udaipur unit that is expected to begin operations by September-October this year. The uni...

Noting that research should not be restricted to government laboratories alone, the union minister said the Centre wants to open research t...

Bengaluru, April 28 (IANS) The energy provided by sunlight in an hour is equivalent to mankind's total energy consumption for one year, but...

The ultimate goal of scientific research should be the benefit of mankind as well as nature, Vikram Sarabhai Space Centre Director M C Dath...

Omar said while patents on innovations may give a sense of ownership to the innovation and science entrepreneur, the benefits of science sh...

Scientists from 74 nations gathered today for a 9-day mega meet that will discuss contemporary topics in the realm of space.

International IT experts have urged governments worldwide to promote the use of open source software as a cost-effective option.

The implications of global warming, already described as the greatest challenge for mankind in the 21st century, could be particularly seve...

The implications of global warming, already described as the greatest challenge for mankind in the 21st century, could be particularly seve...

Unlisted drug maker Mankind Pharma Ltd hopes this year to sell upto 10 per cent of its equity to domestic investors in a bid to raise funds...

Delhi-based Mankind Pharma is holding parleys with some of the leading private equity funds for a private placement deal.